Spartan Wealth Advisory Services LLC Makes New Investment in Astera Labs, Inc. $ALAB

Spartan Wealth Advisory Services LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the first quarter, HoldingsChannel.com reports. The fund purchased 8,446 shares of the company’s stock, valued at approximately $926,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Reflection Asset Management bought a new stake in shares of Astera Labs during the fourth quarter worth $25,000. Smartleaf Asset Management LLC raised its holdings in shares of Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares during the period. Aventura Private Wealth LLC bought a new stake in Astera Labs in the 4th quarter valued at $33,000. Hilltop National Bank lifted its position in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares in the last quarter. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in Astera Labs in the 4th quarter worth $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB opened at $303.62 on Monday. The stock has a market capitalization of $52.04 billion, a price-to-earnings ratio of 205.15, a PEG ratio of 3.42 and a beta of 3.66. Astera Labs, Inc. has a 12 month low of $96.79 and a 12 month high of $499.48. The firm has a fifty day simple moving average of $349.32 and a 200 day simple moving average of $220.94.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts predict that Astera Labs, Inc. will post 1.88 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ALAB has been the subject of a number of research reports. Morgan Stanley increased their target price on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn initiated coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target on the stock. Roth Capital reaffirmed a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a research report on Wednesday, May 6th. Stifel Nicolaus increased their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Finally, Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $275.75.

Insiders Place Their Bets

In related news, Director Bethany Mayer sold 686 shares of Astera Labs stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total transaction of $270,997.44. Following the completion of the sale, the director owned 5,550 shares of the company’s stock, valued at approximately $2,192,472. The trade was a 11.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the completion of the transaction, the director owned 57,466 shares in the company, valued at approximately $25,859,700. This trade represents a 5.75% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,676,845 shares of company stock worth $444,928,806 in the last quarter. Company insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.